BACKGROUND:Breastfed infants require supplementation with vitamin D (vD), but little is known about the necessary dose. This double blind trial evaluated four different doses of vD. METHODS:Exclusively breastfed infants (N = 213) were randomized at 1 mo to one of four doses, which they received through 9 mo while receiving no formula. The supplements provided daily 200 IU, 400 IU, 600 IU, or 800 IU of vD. The primary endpoint was plasma 25(OH)D level, and secondary outcomes were plasma parathyroid hormone and calcium, and illness incidence. The study was conducted during winter at 41° N. RESULTS: Most infants had low (<50 nmol/l) 25(OH)D levels at 1 mo, but with supplementation levels rose. Overall, levels of 25(OH)D differed significantly in proportion to vD dose. There were no effects of vD on illness incidence or growth. Low levels were common, with 7.8% of levels being <50 nmol/l and 15 infants having 2 to 4 low levels. CONCLUSION: The four doses of vD produced different plasma levels of 25(OH)D. The higher doses were somewhat more efficacious in maintaining vD sufficiency in breastfed infants. The findings support the recommended dose of 400 IU/d, and stress the need to start supplementation at birth.
RCT Entities:
BACKGROUND: Breastfed infants require supplementation with vitamin D (vD), but little is known about the necessary dose. This double blind trial evaluated four different doses of vD. METHODS: Exclusively breastfed infants (N = 213) were randomized at 1 mo to one of four doses, which they received through 9 mo while receiving no formula. The supplements provided daily 200 IU, 400 IU, 600 IU, or 800 IU of vD. The primary endpoint was plasma 25(OH)D level, and secondary outcomes were plasma parathyroid hormone and calcium, and illness incidence. The study was conducted during winter at 41° N. RESULTS: Most infants had low (<50 nmol/l) 25(OH)D levels at 1 mo, but with supplementation levels rose. Overall, levels of 25(OH)D differed significantly in proportion to vD dose. There were no effects of vD on illness incidence or growth. Low levels were common, with 7.8% of levels being <50 nmol/l and 15 infants having 2 to 4 low levels. CONCLUSION: The four doses of vD produced different plasma levels of 25(OH)D. The higher doses were somewhat more efficacious in maintaining vD sufficiency in breastfed infants. The findings support the recommended dose of 400 IU/d, and stress the need to start supplementation at birth.
Authors: Boris Novakovic; John C Galati; Anna Chen; Ruth Morley; Jeffrey M Craig; Richard Saffery Journal: Am J Clin Nutr Date: 2012-05-30 Impact factor: 7.045
Authors: Steven A Abrams; Keli M Hawthorne; Stefanie P Rogers; Penni D Hicks; Thomas O Carpenter Journal: BMC Pediatr Date: 2012-01-16 Impact factor: 2.125
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: S Gallo; T Hazell; C A Vanstone; S Agellon; G Jones; M L'Abbé; C Rodd; H A Weiler Journal: Osteoporos Int Date: 2016-03-11 Impact factor: 4.507
Authors: Antonio Corsello; Gregorio Paolo Milani; Maria Lorella Giannì; Valeria Dipasquale; Claudio Romano; Carlo Agostoni Journal: Healthcare (Basel) Date: 2022-06-01
Authors: My Tuyen Thi Nguyen; Jieun Kim; Hyunjun Lee; Soyoon Won; Yongki Kim; Ji A Jung; Dan Li; Xuan Hong Mai To; Khanh Trang Nguyen Huynh; Thanh Van Le; Beenish Israr; Hyun Joo An; Jaehan Kim Journal: Nutrients Date: 2020-06-17 Impact factor: 5.717
Authors: Katrina J Allen; Mary Panjari; Jennifer J Koplin; Anne-Louise Ponsonby; Peter Vuillermin; Lyle C Gurrin; Ronda Greaves; Natalie Carvalho; Kim Dalziel; Mimi L K Tang; Katherine J Lee; Melissa Wake; Nigel Curtis; Shyamali C Dharmage Journal: BMJ Open Date: 2015-12-16 Impact factor: 2.692